[{"title": "IO Biotech's cancer vaccine shows improvement, but narrowly misses study goal - Reuters", "description": "<a href=\"https://news.google.com/rss/articles/CBMi2wFBVV95cUxOd1RvaW55T0ZqRFRQSVdCblFHRXNjM1Zjdl9qcFlOVnRqTXRHeDhBcVZxSGRWSGlQSkoxWVo4Nm9qUXJRUzlNZ2hRRUJ1LWJLS2NjMldwTHdGdUZWaGZRcEZVbkxXM0g3OE4yMFlyLXZaM1ZjTjVhVWN6cEFqeVQ0elpHeDhGRzBxV1FlNFhuRUs1c3JMNWpEUVlEa21fR0t4MjlLWHBkQ3dZYU8zSHM0SWdjVWJ6MEdyand5and3SVZtcHl3dWs2c1MwOVQ3eEUyUmw3VVBjQmY1dm8?oc=5\" target=\"_blank\">IO Biotech's cancer vaccine shows improvement, but narrowly misses study goal</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>", "publishedAt": "Tue, 12 Aug 2025 13:40:32 GMT"}, {"title": "IO Biotech stock jumps on data for cancer shot (IOBT:NASDAQ) - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxOWFRQVi1yelpaUU9kNkZTOS1SOHA1ZGZBNmt0SEI5MkhaTHFsT1djMFllSFlucWtJdVFhNFZldjRTaTNzR1NpV3JidUhYYlRvQU1Dc3VnZTFrM1ZiMkQ2V28xaVJvNF9MUHJrazJMRkx5SmxPXzFzbHdWWXhSRDVVYUdvaw?oc=5\" target=\"_blank\">IO Biotech stock jumps on data for cancer shot (IOBT:NASDAQ)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Mon, 11 Aug 2025 12:29:54 GMT"}, {"title": "Major Phase 3 Results Coming: IO Biotech's Novel Melanoma Treatment Could Challenge Standard of Care - Stock Titan", "description": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQa3oxZlJIcmV0UGhnMXAyRFdDX0xWRDhvRkEteEhpemU5cUJKVUpmRW9QUDR4OUNHYnpIanRaMlhta1ZYLUF5RzJLTnlTUHF3STRuMFFhTVh3VmFuRDNVNC1mcWFETGtoZkNpZXZNRE9XVzFYNmZpZEVlaDA2Wld5c1VWbE5kSUJaOGFKd1EwY3VqSExUajQzYmlrNmo1QXZ1WGJkUlQtdFNWd3AyWDd3MTRVbEwyTU82WGVXU21R?oc=5\" target=\"_blank\">Major Phase 3 Results Coming: IO Biotech's Novel Melanoma Treatment Could Challenge Standard of Care</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stock Titan</font>", "publishedAt": "Sun, 10 Aug 2025 12:00:00 GMT"}, {"title": "Why Is IO Biotech Stock Falling Monday? - IO Biotech (NASDAQ:IOBT) - Benzinga", "description": "<a href=\"https://news.google.com/rss/articles/CBMi3wFBVV95cUxORGkzNWlMVlRqQWo2WW5vU1YwNVo5N29zbk5rbU1FaldZY1ZSODJzN0RVUzFCczhaRFRPY3BxUXJPbEU0UmExOFdfYWFEU1BNV1ZSaVdMQTF1ODJTV2Y2VkhzT3dZc252Z2dwZHlRQ0tWaVNqRXVwSV9YbUN3TmhScDNIeEJfTzlDRU5WUkhSRVpnZG9BUlg4Rk44LTFncXVoeGxpZGlGY3lNQnFXZktEOEM0eE5iS1lFUkNVaThFWEpLVDhlb1NIN0lySnlzcUstbmFYWGpGdjBOUUtEUkln?oc=5\" target=\"_blank\">Why Is IO Biotech Stock Falling Monday? - IO Biotech (NASDAQ:IOBT)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>", "publishedAt": "Mon, 11 Aug 2025 14:09:05 GMT"}, {"title": "IO Biotech\u2019s Experimental Vaccine Shakes Market - StocksToTrade", "description": "<a href=\"https://news.google.com/rss/articles/CBMidkFVX3lxTFBJQ28td295cjNPSHRERUl3TnR6RTdVcFE4VFhST2NqaFRvOUhMRDNvQzVCY09QNWs3Zzk0Y0lVMDJyeWxtRkJ0TUYzNlNMSWRiODQ2dzNpcE5tSVAwOWtQNGdfYzg5ckRZRUs4RGNtWGxLYUZtblE?oc=5\" target=\"_blank\">IO Biotech\u2019s Experimental Vaccine Shakes Market</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">StocksToTrade</font>", "publishedAt": "Fri, 15 Aug 2025 14:04:00 GMT"}, {"title": "IO Biotech Plans Cylembio Filing Despite \u2018Narrowly Missed\u2019 Phase III Endpoint - insights.citeline.com", "description": "<a href=\"https://news.google.com/rss/articles/CBMi9gFBVV95cUxON2xSM2tsN2pib193SXprVUxFZnhDbzk3YjJmOUhDaE0xdGM3LUpPNHRsY1hSV05rMXlRaVhIeklIeEtxUEZJRlROT1NMb1lYcUtWbFRUZ3RZZWNzR0s5eG9YdnFtOEFHSkZSbjhGQldtTkI4ODB5YTRkb250MDJoQlJEQmVESlZ2akR0MllObHNLN2pYMjRpeE4xNDI5MklZOWZ6OVUwUFN3WHdlSGxuSF9OUFBSVm9zeEstM1E4aXA3S0xDX3FTQXRLU0VVV0NvQmdpd1Z6T3VCYVRkelVNZHZmVWhESnpZQS1WY19uZTRYZ3Ffb1E?oc=5\" target=\"_blank\">IO Biotech Plans Cylembio Filing Despite \u2018Narrowly Missed\u2019 Phase III Endpoint</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">insights.citeline.com</font>", "publishedAt": "Mon, 11 Aug 2025 22:12:26 GMT"}, {"title": "IO Biotech, Inc.'s (NASDAQ:IOBT) Market Cap Dropped US$72m Last Week; Private Equity Firms Bore the Brunt - \u5bcc\u9014\u725b\u725b", "description": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxOTjctdXdlOWJOUFdoQ1RrUjRmaXZvQ245bHNMMWp1N1lJc2pKcEFXRnNtS3RBYkRPMWtwVkJudnhTeTdScUgzeXl5eFR4SUhhT1FfMlFyN3B6X0J0bm9MMmpFeVVLTDBUbFYxYVMzcWZyNkI4SkVVYmxOWU4yWFd3LWl5VHFBSDZILWFHU3c3WTRoVjRCelp5ajd3?oc=5\" target=\"_blank\">IO Biotech, Inc.'s (NASDAQ:IOBT) Market Cap Dropped US$72m Last Week; Private Equity Firms Bore the Brunt</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">\u5bcc\u9014\u725b\u725b</font>", "publishedAt": "Tue, 12 Aug 2025 10:09:23 GMT"}, {"title": "IO Biotech shares rise 18.78% premarket ahead of Phase 3 trial results announcement. - AInvest", "description": "<a href=\"https://news.google.com/rss/articles/CBMirAFBVV95cUxQZG05cUZTNU1zV25DMUFNamc1WUpGNFNyZE5EZ21GcGFwSmx0WDdBSUE2TEdfdUxsWHVRVkRtaVNSd2xxUEVJUDlRWUxqUXQ0aVdOMW1fb0VrWXY2TGs3d2QxSmdESTdfcXEzY2J6UFRiX2Y4MmkwTnFSQkV6akM3RVIzLUwzTndpcUZDR1QyOEMtMlhiRmx0eklXbFA3dVc5U3U2cmVCblVfeVVr?oc=5\" target=\"_blank\">IO Biotech shares rise 18.78% premarket ahead of Phase 3 trial results announcement.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>", "publishedAt": "Mon, 11 Aug 2025 09:42:35 GMT"}, {"title": "IO Biotech Shares Jump in Premarket on Positive Melanoma Treatment Trial Data - MarketScreener", "description": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxPTTJxcUkzM0RYdkI5ZVZSY2VfTXZrUllxUGtXVHhDUzBBVTM2N2ZPd3NIWE9VT1N4ZWs5NTREcDN2a3RDU2xlQ1YwT0JlSXdvWkU2bzEtTUQxdVR6NkttaXZGa3pRVzVtZ1pGVVAzY2JwNV81WndmbUV3eVZmME1lbXVZbmZZUTFkQjQzUFdOd2tpajB6SXZpZXBZVTRvWHk1VWVjMDJ2Q2k3WGlkU01KOWN5cTRKLTBDMUNOdXFLQXB5c0lib3R3U0Vn?oc=5\" target=\"_blank\">IO Biotech Shares Jump in Premarket on Positive Melanoma Treatment Trial Data</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketScreener</font>", "publishedAt": "Mon, 11 Aug 2025 12:44:18 GMT"}, {"title": "Is IO Biotech\u2019s Stock Soaring Too High? - timothysykes.com", "description": "<a href=\"https://news.google.com/rss/articles/CBMiekFVX3lxTE50NFNTN0RkZDROLW9mY1ZqMUQ2cjIybUdmNEt3eEZZTGJNelp0LXI3dDh4Z3ZPb3IxaWNMXzJIT1JpeW5aNmpGRWxpWkF6MXVlRjFIMkZ6R21VaWpDLVRpRmY5Q055TTczd2dSMnp6WW5VcUR4RHJFeUN3?oc=5\" target=\"_blank\">Is IO Biotech\u2019s Stock Soaring Too High?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">timothysykes.com</font>", "publishedAt": "Fri, 15 Aug 2025 13:19:00 GMT"}, {"title": "IO Biotech: A Buying Opportunity Following Phase 3 Readout In Melanoma - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMirwFBVV95cUxPMVh3MHFxODZSZHpoZlc4Y2VRRkFvSnhnblZ3WDFhZTZmWFpvaE01Y2w2QnNaUlJLSUt3MXcxWlh1MFRUa1J2a00yb3cxTUl0SFZnellQYmxPSzNNTzVCQ212aFk4SkYwb2NjcmFqd1RES3RCTUs5QzRnMXBNMDVFX2tUQmtTNEtRV3Fnck1tVEFFaDdGSEZ2ZlVGN2xFcGRoanZaWWNxYXhLalQtUzR3?oc=5\" target=\"_blank\">IO Biotech: A Buying Opportunity Following Phase 3 Readout In Melanoma</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Tue, 12 Aug 2025 20:17:41 GMT"}, {"title": "IO Biotech to Announce Topline Results of Pivotal Phase 3 Trial of Cylembio\u00ae in Combination with KEYTRUDA\u00ae (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma - The Manila Times", "description": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">IO Biotech to Announce Topline Results of Pivotal Phase 3 Trial of Cylembio\u00ae in Combination with KEYTRUDA\u00ae (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Manila Times</font>", "publishedAt": "Sun, 10 Aug 2025 12:02:26 GMT"}, {"title": "Clinical Trial Results: IO Biotech's Melanoma Drug Nearly Doubles Survival Time vs Standard Treatment - Stock Titan", "description": "<a href=\"https://news.google.com/rss/articles/CBMitwFBVV95cUxNN1lZWl9MZHY1cm1laFc1Y3JBLXVIR2NzNHRHV3A2QXZ3VnRoTUxHN2ZvWVFIMko0VXpNblYyMVgxbDhWd2tuOXJhTXRET0FBT3QyTkFCUTZVWE5NUmNkUXlZTGpmNDdTa0RuTzNpLU40RWZhS09iNXNoQjF3em1ibnQwMTU4VG5zTGN3ZzMwTWVkUVdNb0lwZEZZRmlycXk5enVkbFdPVHhkdnNIWmN2dVR5eW0xTU0?oc=5\" target=\"_blank\">Clinical Trial Results: IO Biotech's Melanoma Drug Nearly Doubles Survival Time vs Standard Treatment</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stock Titan</font>", "publishedAt": "Mon, 11 Aug 2025 12:00:00 GMT"}, {"title": "IO Biotech shares fall 2.29% premarket after Phase 3 trial results narrowly missed statistical significance. - AInvest", "description": "<a href=\"https://news.google.com/rss/articles/CBMi0AFBVV95cUxPakNvdmhwdjZVM25rVUQzZy1mdGs1Q055UFQyYUNXSHBkYXd4anZSNGh5UW1PSWt1N0QwUUVUeWEwMGpGUVhGUUZSRU1XX3V3TzV3SDZoTWhwT3dPajlTRmdDWWVNMGpMWXdvSTFzeWNrYjhKNXREVTA1YWVKUnVtZnFJU0pRT0E5WHdkdkx0YU9EUDEtR3FRYmtjOWJvdEh1NlFZSGJUZkNMNzhnMmRqQXJXekp2aUxSaTFhT1YycHBsUWU5dklEdmx0bHdKNWpn?oc=5\" target=\"_blank\">IO Biotech shares fall 2.29% premarket after Phase 3 trial results narrowly missed statistical significance.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>", "publishedAt": "Wed, 13 Aug 2025 09:16:16 GMT"}, {"title": "Pharma Boom: What\u2019s Up With IO Biotech? - timothysykes.com", "description": "<a href=\"https://news.google.com/rss/articles/CBMiekFVX3lxTFA5OEVXUW1tY1NWNFQtSUswdlM1ZHMyRzlVWFB2MWFraE1kM0dfODJ2N3RZbHV4Z0lFN1MtRDlRZ1ltb1hBWnFLdUR4OUhtUEo4VnJHVkUtVnFyd3dBdXBiTFNtSHpwVFJIb1ZtQ2J1aDFjNjhrTHRCZzFB?oc=5\" target=\"_blank\">Pharma Boom: What\u2019s Up With IO Biotech?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">timothysykes.com</font>", "publishedAt": "Mon, 11 Aug 2025 13:19:00 GMT"}, {"title": "IO Biotech announces clinical improvement in progression free survival demonstrated in pivotal phase 3 trial of cylembio plus Keytruda (pembrolizumab) for the treatment of first-line advanced melanoma, but statistical significance narrowly missed - MarketScreener", "description": "<a href=\"https://news.google.com/rss/articles/CBMi6AFBVV95cUxQajNtdGlJTnE1V2dPVmh3VklRM1JQbnFZcmRIUW41ZWVld0dsaWxvbTlCVXc4SHpMbFF6TTNkZTJEOFF3VXZiblEyWVk4eWpKS29ablJRbTlEMVUtcDdzNmY2TllQZHdhbzNCZEJ0TjRoQXNQcXdRWkxVNkdiS0VKQlBqdjF1VlhaTG9JUXBRVmlXNFdnZTlmVWY3LWd4Wl9XNE12WEt5a1UxRjNoRkxuTWdtTEltWEh1WHVkY1lzMkloN09SOTdNUy1YcFYyT2JFbG5RYlBlS3pVMV9TeU10MlZIbnVaSlNn?oc=5\" target=\"_blank\">IO Biotech announces clinical improvement in progression free survival demonstrated in pivotal phase 3 trial of cylembio plus Keytruda (pembrolizumab) for the treatment of first-line advanced melanoma, but statistical significance narrowly missed</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketScreener</font>", "publishedAt": "Mon, 11 Aug 2025 12:56:12 GMT"}, {"title": "IO Biotech's Phase 3 Trial Fails To Deliver (NASDAQ:IOBT) - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxQeHBObjN3b3hwLTJCbHc5N2NzUzB5S0pJYTh2TkNFa091SWoxVUVHdjB6TjdwNzBsUzhwaFdjWFBfUHFXQkx6dzVJYmZRcGJjX2NFRDdtMGE2aUVTMGsxeW9kSWxjSnpLeDZBQWRNTm1qVDE1cVJVM2RkM2dZamtnRm9td2hqX0F5d3c?oc=5\" target=\"_blank\">IO Biotech's Phase 3 Trial Fails To Deliver (NASDAQ:IOBT)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Mon, 11 Aug 2025 14:25:27 GMT"}, {"title": "IO Biotech's Melanoma Vaccine Trial Falls Short of Statistical Goals Despite Clinical Benefits - Stock Titan", "description": "<a href=\"https://news.google.com/rss/articles/CBMitgFBVV95cUxQQzJyS0VDWGVQaEtYcTdtTXBHTnhzc1BwcThNNmwwdUFiVXdfUGo3QlRMRktvTVRkTmE3U2RhNjZFLXNQd0djbXBlM19DZ0lRc2lQWUg0VGNXN0dZaTNVLUVtdGw3Z2NSS2E5elFnMHVQMTM2LVplbFREbklCbVNJcV9MVGI4SE04VzNtMExYVGVmS2xoVkFJTDY3ZmFyUEVxaGtkOUJBdl9YTmowZXktOHJKRnVBZw?oc=5\" target=\"_blank\">IO Biotech's Melanoma Vaccine Trial Falls Short of Statistical Goals Despite Clinical Benefits</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stock Titan</font>", "publishedAt": "Thu, 14 Aug 2025 20:05:00 GMT"}, {"title": "IO Biotech's Promising Phase 3 Results and FDA Engagement Bolster Buy Rating - AInvest", "description": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPNjlOWkRQNHNKOHRxSjRhSDl5VWNZNnNIeGJoX1hmdnRWbnRMWjBrRFBVZlFrRHV2a0d5UHBhUEc3UVpxUlVaMmNRTUZKSWpIdVVBclRKZ1ExY1ZqanNQRmx2dXVvRHJlczAtaGI0MncyMFl3NUFEOW9CSDZTajBPeUJpcWhmc1gwRTA1VXdnWVJyVGFJbnhGcHBmSGFmemY0YlV6bEpXa3A?oc=5\" target=\"_blank\">IO Biotech's Promising Phase 3 Results and FDA Engagement Bolster Buy Rating</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>", "publishedAt": "Tue, 12 Aug 2025 09:55:42 GMT"}, {"title": "Io Biotech shares rise 16.41% premarket after reporting clinical improvement in pivotal Phase 3 Trial of Cylembio\u00ae plus KEYTRUDA\u00ae. - AInvest", "description": "<a href=\"https://news.google.com/rss/articles/CBMi3AFBVV95cUxNN3hYWDdDb3hmcEdZaU9kM3JSLVNpdkNWaF95TXpYRVA3a2NLODRXYVY2eElQemJCUXoxQUwza3o0cV9yTXpic2RnRWxfMkY4UWpxTEZoYTdxc2FUNUxFYTlzdGtKdV9xdWtiZkVFZnk2d0k3MDdSQUFXcUNmNGdSdDBPUW5wWjEwVzItLXhBZTZBVFd2SW5BMzlJTFZ1ODFobEdyRTVkcGJIelNGUXlfOENaNmhoU21JeW5sOUFLUHlIclo0M2wtLWdNV3hiZDktZnR2UHdNNkNBV284?oc=5\" target=\"_blank\">Io Biotech shares rise 16.41% premarket after reporting clinical improvement in pivotal Phase 3 Trial of Cylembio\u00ae plus KEYTRUDA\u00ae.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>", "publishedAt": "Fri, 15 Aug 2025 09:37:45 GMT"}, {"title": "RSI Reset May Fuel Rebound in IO Biotech Inc. - 2025 Performance Recap & Accurate Intraday Trading Signals - beatles.ru", "description": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOSXNRZFk1UW1HdUU2LUZ1aFlFTlp3Z0o3RWE5Qnp4ZVo1OUdXRlNXVnVvSkZYSmVUN2tqX0p0TUE5TlVjUk9xbFM2YWpSVXVDUUNyNlFBcjlnaU93cEp2WmZOakozdnIwNDNOR2p3MXpXaEt5eUxha2hXdGEtSDRUTl9oTkd2R2dP?oc=5\" target=\"_blank\">RSI Reset May Fuel Rebound in IO Biotech Inc. - 2025 Performance Recap & Accurate Intraday Trading Signals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">beatles.ru</font>", "publishedAt": "Fri, 15 Aug 2025 18:21:28 GMT"}, {"title": "Trendlines Converge \u2014 Decision Point for IO Biotech Inc. - Jobs Report & Free Weekly Chart Analysis and Trade Guides - beatles.ru", "description": "<a href=\"https://news.google.com/rss/articles/CBMilwFBVV95cUxOWkc5OFJFSXZva0VXSXRTSnU1cmt0Qm5xVGRJTTIxMUVvUjJhRnJqUXBzbmdQZG44M3BTRW5GMC1uRG9JZGVEeTBReExPSGxLUWxqUjFyNDFSSmhWQnV3MlhWcUN2Ujd3OV9BbE1hRGhheUZfNUdUd2FocUZfMzRxV1ZNT1BWeTNlQ1M1T243LWNBOVdsdHZF?oc=5\" target=\"_blank\">Trendlines Converge \u2014 Decision Point for IO Biotech Inc. - Jobs Report & Free Weekly Chart Analysis and Trade Guides</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">beatles.ru</font>", "publishedAt": "Thu, 14 Aug 2025 23:56:27 GMT"}, {"title": "IO Biotech Announces Clinical Improvement in Progression Free Survival Demonstrated in Pivotal Phase 3 Trial of Cylembio\u00ae plus KEYTRUDA\u00ae (Pembrolizumab) for the Treatment of First-line Advanced Melanoma, but Statistical Significance Narrowly Misse - The Manila Times", "description": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">IO Biotech Announces Clinical Improvement in Progression Free Survival Demonstrated in Pivotal Phase 3 Trial of Cylembio\u00ae plus KEYTRUDA\u00ae (Pembrolizumab) for the Treatment of First-line Advanced Melanoma, but Statistical Significance Narrowly Misse</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Manila Times</font>", "publishedAt": "Mon, 11 Aug 2025 12:09:38 GMT"}, {"title": "How sensitive is IO Biotech Inc. to inflation - July 2025 Setups & Accurate Entry/Exit Alerts - mustnews.co.kr", "description": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxPaUFqUUx2OVRIZTN4VVJGeDdfOHBPR0lCRFR1VWxLS1M0MFRLci00V0VDLVAyZlZfM29TYmI4TXVYc3NBRnFCQTJoblZ3RmgxUlhQeHh3V3N0UDI4RFVJX3dWTThkODhMTExRZkdrenRhdFhuN0tTQThibk1GbVlHR0tKMA?oc=5\" target=\"_blank\">How sensitive is IO Biotech Inc. to inflation - July 2025 Setups & Accurate Entry/Exit Alerts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">mustnews.co.kr</font>", "publishedAt": "Fri, 15 Aug 2025 23:52:25 GMT"}, {"title": "Using fundamentals and technicals on IO Biotech Inc. - Portfolio Gains Summary & Growth Focused Entry Point Reports - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOQktZaVE4VmN6aHJsT2MyS2NNdWZUcmFOOERaZ0d1MHZTUVdoanNXQU1QRGg0enpCVFhCTmhjdUhCbEllMnIzZlVvYnBpMEQ4eXRYRVNwVS1LZW5XWGRBcHQ2YTViWWpwWXA2Y1RkOUtfM3dmaFdISm9UaHRpeU5ZWjc4a0ZtLU9uUnFZ?oc=5\" target=\"_blank\">Using fundamentals and technicals on IO Biotech Inc. - Portfolio Gains Summary & Growth Focused Entry Point Reports</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Sat, 16 Aug 2025 06:43:35 GMT"}, {"title": "Combining machine learning predictions for IO Biotech Inc. - 2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxOTUJBeGxLU1otYmRiZ2JvQU1Ob3ZCRENfSUhyV21Kc3VjMmhzOHhiYzJzZDhBTjNJV3JlUXVRUXpNcnZveUVPdFFQR0ExWTEtUWhCdEJodjdkR01LUGVJRjRKanFDMWhfTjFnNjNjcGxTMUtxWGVIaFBHWEpkdHE0cWo0bHpNeEZxQzk3d0RJc29XeWc?oc=5\" target=\"_blank\">Combining machine learning predictions for IO Biotech Inc. - 2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Sat, 16 Aug 2025 06:46:47 GMT"}, {"title": "Strategies to average down on IO Biotech Inc. - Share Buyback & Low Drawdown Momentum Ideas - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxPNmRyOHR3TlRQLVB3U1JPVWhPcl9ROXJSSk1iUW5nc2FVaDZQRXRKSUVsVU1RMDJYTUhqTFVzSDZKbnFwZjZhT0s1aVU1OUh0SGtzdWxua21TLUNwRXRoU1d5aEFCZVZMWjBUUmYzRkRKbVVsZTVmRVdpNXJfb2p4cDFmRThCQQ?oc=5\" target=\"_blank\">Strategies to average down on IO Biotech Inc. - Share Buyback & Low Drawdown Momentum Ideas</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Sat, 16 Aug 2025 10:47:36 GMT"}, {"title": "Price momentum metrics for IO Biotech Inc. explained - July 2025 Reactions & Daily Profit Focused Screening - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMijwFBVV95cUxQUllROEw1VDV5Z2NLOG5ZQzdIRzR3VnlLTm9iTkZnYVlucXdvNUVQSGcwSXVPaE04TVhwX29KQm8wVlFYaTh0Tl81NFdsQTNYeFF1NEdwUXVMY3lNUVBMMTFDNWhsMlFlLXZYX2pLb3ZfUzhnQmNOMXZwSDNfTWp1WGJvblJPN0Q4ZE5zNWZyZw?oc=5\" target=\"_blank\">Price momentum metrics for IO Biotech Inc. explained - July 2025 Reactions & Daily Profit Focused Screening</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Sat, 16 Aug 2025 08:11:55 GMT"}, {"title": "Combining machine learning predictions for IO Biotech Inc. - 2025 Market Outlook & Daily Volume Surge Trade Alerts - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMilwFBVV95cUxOakRuYzlHdUh4QS1WN3dHRkpqTzBqcnZ6ZEtfY0F6eXdoR3RIYmZ2TXJhdUs1c1FSVmE0UVZNWWEtZDMxcjFOZExEa3ZfZWdIa2d4cVk3ZGEtOTJnc3FSQ0JJY0doWmRMZ3BSWkY1WW1rWEJlVzBZblpDcHhpV2tmZldOZDVzdldBYVFnWkRkNWNPejgtdmk0?oc=5\" target=\"_blank\">Combining machine learning predictions for IO Biotech Inc. - 2025 Market Outlook & Daily Volume Surge Trade Alerts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Sat, 16 Aug 2025 10:52:58 GMT"}]